Cargando…

Nucleolin Aptamer N6L Reprograms the Translational Machinery and Acts Synergistically with mTORi to Inhibit Pancreatic Cancer Proliferation

SIMPLE SUMMARY: Pancreatic cancer is an aggressive disease characterized by its invasiveness, rapid progression, and resistance to conventional therapy. There is a need to identify new molecules to improve current therapies. The aim of this study was to analyze how the pancreatic cancer cells react...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chalabi-Dchar, Mounira, Cruz, Elisabeth, Mertani, Hichem C., Diaz, Jean-Jacques, Courty, José, Cascone, Ilaria, Bouvet, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508287/ https://www.ncbi.nlm.nih.gov/pubmed/34638443 http://dx.doi.org/10.3390/cancers13194957

Ejemplares similares

Timing of mTORI usage and outcomes in kidney transplant recipients
por: Lim, Lee-Moay, et al.
Publicado: (2021)

Nucleolin Targeting by N6L Inhibits Wnt/β-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma
por: Raineri, Fabio, et al.
Publicado: (2021)

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression
por: Ponzo, Matteo, et al.
Publicado: (2022)

Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin
por: Kumar, Sanjeev, et al.
Publicado: (2017)

Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265
por: Ponzo, Matteo, et al.
Publicado: (2022)

Clinical Benefit of Niraparib to TKI/mTORi-Resistance Metastatic ccRCC With BAP1-Frame Shift Mutation: Case Report and Literature Review
por: Lian, Bi-Jun, et al.
Publicado: (2022)

A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate
por: Chalabi-Dchar, Mounira, et al.
Publicado: (2021)

Insights into the binding mode of AS1411 aptamer to nucleolin
por: Bie, Lihua, et al.
Publicado: (2022)

Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023)

The Tory Doctors of Georgia under the Banishment Act of 1778
por: Krafka, Joseph
Publicado: (1938)

AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation
por: Iturriaga-Goyon, Emilio, et al.
Publicado: (2021)

The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells
por: Ramos, Kenneth S., et al.
Publicado: (2020)

Complex Tori
por: Birkenhake, Christina, et al.
Publicado: (1999)

Tortured tori
por: Nilles, Hans Peter
Publicado: (1987)

Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L
por: Birmpas, Charalampos, et al.
Publicado: (2012)

Expression of Nucleolin Affects Microtubule Dynamics
por: Gaume, Xavier, et al.
Publicado: (2016)

Grafting of anti-nucleolin aptamer into preformed and remotely loaded liposomes through aptamer-cholesterol post-insertion
por: Nsairat, Hamdi, et al.
Publicado: (2020)

The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis
por: Birmpas, Charalampos, et al.
Publicado: (2012)

Rationality problem for algebraic tori
por: Hoshi, Akinari, et al.
Publicado: (2017)

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry–based imaging
por: Subramanian, Nithya, et al.
Publicado: (2016)

Myogenetic Oligodeoxynucleotides as Anti-Nucleolin Aptamers Inhibit the Growth of Embryonal Rhabdomyosarcoma Cells
por: Nohira, Naoki, et al.
Publicado: (2022)

In vivo Study of the Histone Chaperone Activity of Nucleolin by FRAP
por: Gaume, Xavier, et al.
Publicado: (2011)

Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting
por: Miranda, André, et al.
Publicado: (2021)

The Pursuit of Virtue and Other Tory Notions /
por: Will, George F.
Publicado: (1982)

Construction of invariant tori in chaotic regions
por: Kaasalainen, M
Publicado: (1995)

Non-Planar String Networks on Tori
por: Kumar, Alok
Publicado: (2000)

Unfoldings and bifurcations of quasi-periodic tori
por: Broer, HW, et al.
Publicado: (1990)

Mandibular tori as an incidental finding in MRI
por: Platzek, Ivan, et al.
Publicado: (2014)

Oral Tori in Chronic Hemodialysis Patients
por: Chao, Pei-Jung, et al.
Publicado: (2015)

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
por: Li, Fangfei, et al.
Publicado: (2017)

Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
por: Holmboe, Sif, et al.
Publicado: (2017)

Symplectic actions of 2-tori on 4-manifolds
por: Pelayo, Alvaro
Publicado: (2010)

Sperm morphology in Estonian and Tori Breed Stallions
por: Kavak, A, et al.
Publicado: (2004)

Linear representation of quasisplit tori and problem of rationality
por: Voskresenskii, V E
Publicado: (2000)

Construction on invariant tori around closed orbits
por: Kaasalainen, M
Publicado: (1995)

A possible mechanism for the KAM tori breakdown
por: Gentile, G, et al.
Publicado: (1996)

Tame sets, dominating maps, and complex tori
por: Buzzard, G T
Publicado: (1999)

Stability of KAM tori for nonlinear Schrödinger equation
por: Cong, Hongzi, et al.
Publicado: (2016)

Oral Tori in Chronic Peritoneal Dialysis Patients
por: Hsu, Chia-Lin, et al.
Publicado: (2016)

Reducible KAM Tori for the Degasperis–Procesi Equation
por: Feola, Roberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0bo2gi9dejp6ckvn8e00vle9rn